ProACTIVE SCI Physical Activity Intervention

Sponsor
University of British Columbia (Other)
Overall Status
Completed
CT.gov ID
NCT03111030
Collaborator
Rick Hansen Institute (Other), Ontario Neurotrauma Foundation (Other), International Collaboration on Repair Discoveries (Other)
28
2
2
15.1
14
0.9

Study Details

Study Description

Brief Summary

This study will employ a randomized, wait-list controlled trial. A total of 30 participants (15 experimental, 15 wait-list control) between 18-65 years of age who have chronic SCI ≥ 1 year prior will be recruited. Physical activity measures will be taken using wrist-based accelerometers and the Leisure Time Physical Activity Questionnaire for people with SCI (LTPAQ). Psychosocial factors will be evaluated through questionnaires. The primary health outcome measure (aPWV), and secondary cardiovascular parameters will be assessed using a combination of echocardiography and ultrasound. Fitness will be determined using a peak oxygen consumption test on an arm-cycle ergometer. All measurement will be taken at baseline and after 9 weeks following intervention commencement. Physical activity will also be sampled mid-intervention at 4 and 7 weeks. Training will involve weekly, 10-15 minute coaching sessions for 9 weeks. All pre- and post-assessments will take place at the Blusson Spinal Cord Centre at ICORD. Intervention content will be delivered in-person, over Skype or phone, and the wrist- worn accelerometers will be delivered and picked up from the participant's home during the intervention.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: ProacTive SCI
N/A

Detailed Description

A randomized, wait-list controlled trial will be used to compare the effects of tailored PA coaching sessions versus no coaching on PA behaviour, psychosocial factors, and health outcomes. Eligible individuals will be randomly assigned (1:1) to either the experimental (PA coaching sessions) or wait-list control condition. Matched randomization based on baseline physical activity levels will be used. The randomization sequence will be generated by a research assistant independent of the trial.

Day 1 testing measures include vascular measures (arterial pulse wave velocity, arterial structure; 30 minutes), cardiac structure and function measures (30 minutes), a peak oxygen uptake test (60 minutes), for a total duration of 2 hours. Participants will be given an accelerometer to wear for the 6-day monitoring period (6.1.2) after which they will return for Day 2 testing.

Day 2 testing measures include administration of the LTPAQ (5 minutes), administration of the demographics and Health Action Process Approach model questionnaire (25 minutes), and a measurement of energy expenditure at different sub-maximal wheeling speeds to calibrate MVPA cut-points (30 minutes) and at baseline, the first PA coaching session will be administered (60 minutes) whereas at post-test a semi-structured interview will be administered (60 minutes). Total duration of day 2 testing will be 2 hours. The intervention protocol is described below. During the intervention, physical activity will be sampled at two time points; accelerometer and PARA SCI data will be taken during week 4 and week 7.

INTERVENTION

Intervention Protocol:

Experimental participants will receive weekly PA coaching sessions. Each session will be 10-15 minutes in duration and delivered either face to face, over Skype, or when the former modes are unavailable, over the phone. Additionally, supplemental resources may be emailed to the participants based on need throughout the intervention.

Participants' motivation to exercise will first be determined according to stages of the HAPA model. Those who identify as pre-intenders (no intention to exercise) will receive intervention strategies that focus on changing motivation to be physically active. Those identified as intenders (willing to exercise but have not started) will focus on providing resources and behavioural strategies to commence physical activity. Lastly, those identified as actors (already exercising) will receive intervention strategies that help participants maintain or improve PA behaviour.

For those in the intender or actor stage, the intervention aims to promote the international SCI PA guidelines to promote fitness (at least 20 minutes of moderate vigorous aerobic activity twice/week and strength training twice/week). For those exceeding the fitness guidelines, the international SCI PA guidelines to promote health are promoted (at least 30 minutes of moderate to vigorous aerobic activity three times/week and strength training twice/week). However, these aims will be modified based on the individual's baseline PA. During the first visit, participants' baseline PA levels will be reviewed and an appropriate PA goal to achieve in the following month will be formed. Ultimately, the goal is the decision of the participant.

Following goal setting, barriers to participating in PA will be identified. The interventionist will select intervention strategies based on the identified barriers. A pre-formed chart of corresponding intervention strategies (e.g. use of behaviour change techniques, referral to facilities or peers, suggesting at-home exercises) was developed to aid this pairing process (Appendix A). These intervention strategies are accompanied by a comprehensive toolkit based from the HAPA model (Appendix B). In brief, the toolkit advises on three key strategies for promoting PA to people with SCI: i) education, ii) referral, iii) tailored PA prescription.

Remaining weekly coaching sessions will review participants' progress and barriers to discuss new goals and strategies as outlined above.

Control Participants:

Control participants will complete baseline and post-testing only. Following completion of post-test measures they will be administered the same PA coaching session as the intervention group, with post-test measures being repeated upon intervention completion.

Study Design

Study Type:
Interventional
Actual Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
ProACTIVE SCI Physical Activity Coaching Intervention
Actual Study Start Date :
Apr 28, 2017
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Aug 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: ProacTive SCI

Individualized physical activity coaching sessions

Behavioral: ProacTive SCI
Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed.

No Intervention: Wait-list control

Standard care, receiving physical activity coaching sessions after completing post-testing

Outcome Measures

Primary Outcome Measures

  1. Change in Physical Activity: Leisure Time Physical Activity Questionnaire for People With SCI (LTPAQ) [Baseline, week 4, week 7, week 10, 6 month follow up]

    Participants will be asked to complete a questionnaire, guided by the co-investigator (Jasmin Ma), that asks the participant to recall in the last 7 days how many days and for how long leisure time physical activity was performed. The recall assessment will take approximately 5 minutes to complete.

  2. Change in Total Accelerometer Count as a Measure of Change in Physical Activity: 6-day Physical Activity Monitoring Period [Baseline, week 4, week 7, week 10]

    Participants will be fitted with a wrist-based tri-axial accelerometer to be worn 24 hours a day for 6 days in order to determine intensity and amount of PA. They will keep a detailed PA diary recording all leisure time PA performed during the day. The primary outcome will be total vector magnitude (VM) accelerometer counts from a tri-axial wrist-worn accelerometer (GT9X, ActiGraph LLC, FL). During the intervention, the accelerometer will be picked up and dropped off to the participant's home to decrease burden. Text or email reminders (i.e. "Please don't forget to wear your accelerometer today") will be used to promote adherence to accelerometer wear.

Secondary Outcome Measures

  1. Change in Health Action Process Approach Model Measure [Baseline, 9 weeks from intervention start (week 10)]

    This survey will examine psychological factors that may affect PA participation. The survey will be recorded either electronically or with pen and paper depending on the respondent's preference. Survey will take approximately 25 minutes to complete, and will assess constructs related to exercise such as perceived risks, self- efficacy, planning, and social support. The demographics questionnaire will also be administered with this measure. All items will be assessed on a 7-point Likert scale ranging from 1 = "strongly disagree" to 7 = "strongly agree". Higher scores indicate a better outcome.

  2. Number of Participants Participating in Qualitative Interviews [9 weeks from intervention start (week 10)]

    A semi-structured interview will be conducted at the end of the intervention to understand what components were and were not effective. Data will not be recorded. This feedback will be used to improve future iterations of the intervention. There is no associated scale with this measurement.

  3. Change in Pulse Wave Velocity [Baseline, 9 weeks from intervention start (week 10)]

    aPWV (cm/s) is calculated by dividing the distance between measurement sites, by the pulse transit time. Distance between the carotid and femoral arteries will be measured using measuring tape along the surface of the body, held parallel to the testing table. The pulse transit is determined from the arterial blood pressure waves, which are collected at each arterial site. A pen-like device (model SPT-301; Millar Instruments Inc., Houston, TX) will be applied to the carotid and femoral arterial sites using a light pressure to obtain arterial pressure waves. Heart rate will be recorded using a single-lead (lead I) electrocardiogram (ECG) (model ML 123, ADInstruments Inc., Colorado Springs, CO).

  4. Change in Arterial Structure: Wall Thickness [Baseline, 9 weeks from intervention start (week 10)]

    Common carotid arterial images will be collected using B-mode ultrasound (INFO) for 10 cardiac cycles. Images will be analyzed using internal ultrasound software to determine lumen diameter and intima-media thickness.

  5. Change in End Systolic Volume [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  6. Change in End Diastolic Volume [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  7. Change in Intraventricular Septum Diameter [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  8. Change in Ventricular Internal Diameter [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  9. Change in Systolic Function [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. LV stroke volume will be used to measure change in systolic function.

  10. Change in Ejection Fraction [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  11. Change in Cardiac Output [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.

  12. Change in Fractional Shortening [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. Longitudinal strain will be used to measure change in fractional shortening.

  13. Change in Diastolic Function [Baseline, 9 weeks from intervention start (week 10)]

    Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. E'/A' (ratio between early diastolic septal tissue velocity and late diastolic septal tissue velocity) will be used to measure change in diastolic function.

  14. Aerobic Fitness Evaluation: Peak Oxygen Uptake Test (VO2peak) [Baseline, 9 weeks from intervention start (week 10)]

    Participants will perform a graded arm ergometer test on an electronically braked arm ergometer. For participants with tetraplegia who have limited handgrip function, gloves will be used to secure hands to the ergometer handles. Participants will be instructed to maintain a cycling rate of 50 revolutions per minute (rpm) for the duration of the test. After an initial warm-up at 0W, power output will be increased each minute at a rate of 2-5 W/min for participants with tetraplegia, or 10 W/min for participants with paraplegia, until volitional exhaustion (i.e. dropping below 30 rpm). Oxygen consumption will be recorded on a breath-by-breath basis for the duration of the test and reported as rolling 30-second averages sampled at 5-second intervals as per consensus recommendations. All outcome data are reported here: https://doi.org/10.1007/s40279-019-01118-5

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Individuals must be competent to give informed consent,

  • be able to propel an arm ergometer.

Exclusion Criteria:
  • History and/or symptoms of CVD or cardiopulmonary problems/disease.

  • Major trauma or surgery within the last 6 months.

  • Active Stage 3 or 4 pressure ulcer (based on the National Pressure Ulcer Advisory Panel classification)

  • Recent (within 1 year) history of lower-extremity or non-union fracture

  • Any unstable medical/psychiatric condition or substance abuse disorder that is likely to affect their ability to complete this study.

  • Individuals with active medical issues such as pressure sores, urinary tract infections, hypertension, or heart disorders.

  • Any cognitive dysfunction or language barrier that would prevent subjects from following English instructions.

  • Subjects may be excluded at the discretion of the principal investigator due to other, unforeseen, safety issues.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of British Columbia Okanagan Kelowna British Columbia Canada V1V 1V7
2 International Collaboration on Repair Discoveries Vancouver British Columbia Canada V5Z 1M9

Sponsors and Collaborators

  • University of British Columbia
  • Rick Hansen Institute
  • Ontario Neurotrauma Foundation
  • International Collaboration on Repair Discoveries

Investigators

  • Principal Investigator: Kathleen Martin Ginis, PhD, University of British Columbia- Okanagan

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Kathleen Martin Ginis, professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT03111030
Other Study ID Numbers:
  • H17-00559
First Posted:
Apr 12, 2017
Last Update Posted:
Mar 9, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Period Title: Overall Study
STARTED 14 14
COMPLETED 14 14
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title ProacTive SCI Wait-list Control Total
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing Total of all reporting groups
Overall Participants 14 14 28
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
45.79
(13.63)
45.57
(10.49)
45.68
(11.93)
Sex: Female, Male (Count of Participants)
Female
5
35.7%
8
57.1%
13
46.4%
Male
9
64.3%
6
42.9%
15
53.6%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
2
14.3%
2
7.1%
Asian
0
0%
0
0%
0
0%
Native Hawaiian or Other Pacific Islander
2
14.3%
2
14.3%
4
14.3%
Black or African American
0
0%
0
0%
0
0%
White
12
85.7%
10
71.4%
22
78.6%
More than one race
0
0%
0
0%
0
0%
Unknown or Not Reported
0
0%
0
0%
0
0%
Region of Enrollment (participants) [Number]
Canada
14
100%
14
100%
28
100%
Leisure Time Physical Activity Questionnaire for People With SCI (LTPAQ) (Total LTPA min/week) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Total LTPA min/week]
212
(195)
274
(300)
243
(248)
Aerobic Fitness Evaluation: Peak Oxygen Uptake Test (VO2peak) (L/min) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [L/min]
1.15
(.36)
1.13
(.43)
1.14
(.41)

Outcome Measures

1. Primary Outcome
Title Change in Physical Activity: Leisure Time Physical Activity Questionnaire for People With SCI (LTPAQ)
Description Participants will be asked to complete a questionnaire, guided by the co-investigator (Jasmin Ma), that asks the participant to recall in the last 7 days how many days and for how long leisure time physical activity was performed. The recall assessment will take approximately 5 minutes to complete.
Time Frame Baseline, week 4, week 7, week 10, 6 month follow up

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
212
(195)
274
(300)
Week 4
393
(413)
NA
(NA)
Week 7
370
(258)
NA
(NA)
Week 10
405
(364)
147
(192)
6 months FU
348
(269)
NA
(NA)
2. Primary Outcome
Title Change in Total Accelerometer Count as a Measure of Change in Physical Activity: 6-day Physical Activity Monitoring Period
Description Participants will be fitted with a wrist-based tri-axial accelerometer to be worn 24 hours a day for 6 days in order to determine intensity and amount of PA. They will keep a detailed PA diary recording all leisure time PA performed during the day. The primary outcome will be total vector magnitude (VM) accelerometer counts from a tri-axial wrist-worn accelerometer (GT9X, ActiGraph LLC, FL). During the intervention, the accelerometer will be picked up and dropped off to the participant's home to decrease burden. Text or email reminders (i.e. "Please don't forget to wear your accelerometer today") will be used to promote adherence to accelerometer wear.
Time Frame Baseline, week 4, week 7, week 10

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
562000
(188000)
848000
(759000)
Week 4
593000
(307000)
NA
(NA)
Week 7
659000
(338000)
NA
(NA)
Week 10
702000
(267000)
598000
(390000)
3. Secondary Outcome
Title Change in Health Action Process Approach Model Measure
Description This survey will examine psychological factors that may affect PA participation. The survey will be recorded either electronically or with pen and paper depending on the respondent's preference. Survey will take approximately 25 minutes to complete, and will assess constructs related to exercise such as perceived risks, self- efficacy, planning, and social support. The demographics questionnaire will also be administered with this measure. All items will be assessed on a 7-point Likert scale ranging from 1 = "strongly disagree" to 7 = "strongly agree". Higher scores indicate a better outcome.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Affective outcome expectancies (Baseline)
5.1
(1.3)
5.7
(0.9)
Affective outcome expectancies (Week 10)
5.6
(1.0)
5.4
(1.0)
Instrumental outcome expectancies (Baseline)
6.5
(0.6)
6.5
(0.9)
Instrumental outcome expectancies (Week 10)
6.8
(0.3)
6.3
(0.8)
Risk perceptions (Baseline)
2.5
(1.6)
2.5
(1.3)
Risk perceptions (Week 10)
2.8
(1.6)
2.5
(1.1)
Aerobic exercise task self-efficacy (Baseline)
3.4
(1.9)
4.1
(1.7)
Aerobic exercise task self-efficacy (Week 10)
4.7
(1.2)
3.6
(1.6)
Strength exercise task self-efficacy (Baseline)
3.9
(1.6)
3.7
(1.6)
Strength exercise task self-efficacy (Week 10)
5.6
(1.2)
3.2
(1.8)
Intentions (Baseline)
6.1
(1.1)
6.5
(0.7)
Intentions (Week 10)
6.8
(0.4)
6.3
(1.2)
Planning self-efficacy (Baseline)
5.9
(0.8)
6.2
(1.1)
Planning self-efficacy (Week 10)
6.0
(0.5)
6.8
(0.4)
Barrier self-efficacy (Baseline)
5.0
(1.2)
4.4
(1.0)
Barrier self-efficacy (Week 10)
5.7
(0.8)
4.7
(1.1)
Scheduling self-efficacy (Baseline)
4.9
(1.5)
5.3
(1.2)
Scheduling self-efficacy (Week 10)
5.7
(1.3)
5.5
(1.1)
Action planning (Baseline)
3.7
(1.9)
3.8
(2.0)
Action planning (Week 10)
6.8
(0.4)
3.6
(2.3)
Monitoring (Baseline)
4.5
(1.6)
4.4
(1.4)
Monitoring (Week 10)
6.3
(0.8)
4.4
(1.3)
Coping self-efficacy (Baseline)
6.0
(0.8)
5.8
(1.2)
Coping self-efficacy (Week 10)
6.3
(0.7)
6.3
(0.7)
Social support (Baseline)
2.2
(1.0)
2.0
(0.8)
Social support (Week 10)
2.8
(0.9)
1.7
(0.5)
Presence of barriers (Baseline)
5.7
(1.5)
5.5
(1.3)
Presence of barriers (Week 10)
6.1
(1.1)
5.0
(1.8)
Knowledge (Baseline)
5.9
(1.1)
5.2
(1.9)
Knowledge (Week 10)
6.7
(0.4)
4.4
(2.0)
4. Secondary Outcome
Title Number of Participants Participating in Qualitative Interviews
Description A semi-structured interview will be conducted at the end of the intervention to understand what components were and were not effective. Data will not be recorded. This feedback will be used to improve future iterations of the intervention. There is no associated scale with this measurement.
Time Frame 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Count of Participants [Participants]
14
100%
0
0%
5. Secondary Outcome
Title Change in Pulse Wave Velocity
Description aPWV (cm/s) is calculated by dividing the distance between measurement sites, by the pulse transit time. Distance between the carotid and femoral arteries will be measured using measuring tape along the surface of the body, held parallel to the testing table. The pulse transit is determined from the arterial blood pressure waves, which are collected at each arterial site. A pen-like device (model SPT-301; Millar Instruments Inc., Houston, TX) will be applied to the carotid and femoral arterial sites using a light pressure to obtain arterial pressure waves. Heart rate will be recorded using a single-lead (lead I) electrocardiogram (ECG) (model ML 123, ADInstruments Inc., Colorado Springs, CO).
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
10.6
(2.9)
8.0
(2.0)
Week 10
9.7
(2.5)
8.2
(1.9)
6. Secondary Outcome
Title Change in Arterial Structure: Wall Thickness
Description Common carotid arterial images will be collected using B-mode ultrasound (INFO) for 10 cardiac cycles. Images will be analyzed using internal ultrasound software to determine lumen diameter and intima-media thickness.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
0.62
(0.16)
0.56
(0.07)
Week 10
0.61
(0.15)
0.56
(0.07)
7. Secondary Outcome
Title Change in End Systolic Volume
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
38
(9)
36
(9)
Week 10
38
(9)
35
(8)
8. Secondary Outcome
Title Change in End Diastolic Volume
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
87
(18)
84
(20)
Week 10
86
(14)
82
(18)
9. Secondary Outcome
Title Change in Intraventricular Septum Diameter
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
This was not measured or reported.
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 0 0
10. Secondary Outcome
Title Change in Ventricular Internal Diameter
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
42
(5)
43
(10)
Week 10
43
(4)
44
(4)
11. Secondary Outcome
Title Change in Systolic Function
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. LV stroke volume will be used to measure change in systolic function.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
49
(9)
48
(11)
Week 10
49
(6)
47
(10)
12. Secondary Outcome
Title Change in Ejection Fraction
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
57
(3)
57
(3)
Week 10
56
(3)
58
(3)
13. Secondary Outcome
Title Change in Cardiac Output
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
3.22
(0.78)
3.05
(0.87)
Week 10
3.13
(0.63)
3.13
(0.96)
14. Secondary Outcome
Title Change in Fractional Shortening
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. Longitudinal strain will be used to measure change in fractional shortening.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
-19.0
(2.6)
-17.5
(4.3)
Week 10
-19.2
(2.7)
-18.1
(3.3)
15. Secondary Outcome
Title Change in Diastolic Function
Description Cardiac image will be collected non-invasively using Doppler ultrasound (Vivid q, GE Healthcare, Buckinghamshire, UK). Image will be collected and stored on the ultrasound for offline analysis. E'/A' (ratio between early diastolic septal tissue velocity and late diastolic septal tissue velocity) will be used to measure change in diastolic function.
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
0.99
(0.21)
1.10
(0.33)
Week 10
1.02
(0.32)
1.14
(0.36)
16. Secondary Outcome
Title Aerobic Fitness Evaluation: Peak Oxygen Uptake Test (VO2peak)
Description Participants will perform a graded arm ergometer test on an electronically braked arm ergometer. For participants with tetraplegia who have limited handgrip function, gloves will be used to secure hands to the ergometer handles. Participants will be instructed to maintain a cycling rate of 50 revolutions per minute (rpm) for the duration of the test. After an initial warm-up at 0W, power output will be increased each minute at a rate of 2-5 W/min for participants with tetraplegia, or 10 W/min for participants with paraplegia, until volitional exhaustion (i.e. dropping below 30 rpm). Oxygen consumption will be recorded on a breath-by-breath basis for the duration of the test and reported as rolling 30-second averages sampled at 5-second intervals as per consensus recommendations. All outcome data are reported here: https://doi.org/10.1007/s40279-019-01118-5
Time Frame Baseline, 9 weeks from intervention start (week 10)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
Measure Participants 14 14
Baseline
1.16
(0.38)
1.13
(0.46)
Week 10
1.30
(0.43)
1.06
(0.40)

Adverse Events

Time Frame Study duration: 10 weeks
Adverse Event Reporting Description
Arm/Group Title ProacTive SCI Wait-list Control
Arm/Group Description Individualized physical activity coaching sessions ProacTive SCI: Participants will receive weekly physical activity coaching sessions. Each session will be 10-15 minutes, delivered either face to face, over Skype, or over the phone. Additional resources may be emailed to participants based on need throughout the intervention (for example, a goal, list of places to exercise, contact information to reach mentoring services). A typical session may include: An assessment of motivated the participant is to be physically active A: If motivated, a physical activity goal will be set, strategies will be reviewed, and resources to accomplish that goal will be provided. B: If not motivated, questions will be asked to understand why the reasons for lack of motivation. If it is for any reasons including barriers, fear, confidence, or knowledge, the interventionist will discuss strategies to overcome these obstacles. Progress and barriers will be reassessed and discussed. Standard care, receiving physical activity coaching sessions after completing post-testing
All Cause Mortality
ProacTive SCI Wait-list Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/14 (0%) 0/14 (0%)
Serious Adverse Events
ProacTive SCI Wait-list Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/14 (0%) 0/14 (0%)
Other (Not Including Serious) Adverse Events
ProacTive SCI Wait-list Control
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/14 (0%) 0/14 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Kathleen Martin Ginis
Organization Unviersity of British Columbia
Phone 250-807-9768
Email Kathleen_martin.ginis@ubc.ca
Responsible Party:
Kathleen Martin Ginis, professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT03111030
Other Study ID Numbers:
  • H17-00559
First Posted:
Apr 12, 2017
Last Update Posted:
Mar 9, 2022
Last Verified:
Jan 1, 2022